



Specialist details how MDMA acts in the brain and the promising results in patients resistant to conventional therapies
Study shows that psilocybin promotes a selective reorganization of brain connections, strengthening sensory and subcortical pathways and weakening feedback circuits between cortical regions
Bill regulating psilocybin therapy advances in New Jersey, allowing supervised use of the substance for therapeutic purposes
Argentina conducts a clinical study with 5-MeO-DMT to treat depression and anxiety, investigating the efficacy and safety of this psychedelic substance in volunteers
Technology inspired by fungi promises cultivated and sustainable chips
Energy Control detected in Spain ecstasy pills with MDMA doses exceeding 360 mg, more than double the limit considered high potency by the European Drug Agency
Research indicates that psilocybin can offer serenity to end-of-life patients, combining science, empathy, and a new perspective on dying
Research indicates that psilocybin can offer serenity to end-of-life patients, uniting science, empathy, and a new perspective on dying
The research, conducted by the Neuroscience Laboratory at UNILA, aims to advance the treatment of mental disorders through new scientific approaches
Research on psilocybin points to a new frontier in chronic pain treatment, combining science and empathy to offer lasting relief and better quality of life to millions of people
Indigenous peoples warn of the risk of exclusion in discussions about the legalization of psychedelics and call for respect for ancestral knowledge
Research reveals that psychedelic substances, such as psilocybin and LSD, may have anti-inflammatory action, opening up new therapeutic possibilities and reinforcing the connection between mind and body in modern medicine